The Food and Drug Administration approved United Therapeutics Corp.’s (Nasdaq: UTHR) high blood pressure medication Orenitram sending the stock price soaring $26.67 to close at $114.51.
United Therapeutics’ Orenitram Approved
December 23, 2013 at 09:34 AM EST
